共 52 条
[1]
Yusuf S., Reddy S., Ounpuu S., Et al., Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization, Circulation, 104, 22, pp. 2746-2753, (2001)
[2]
Yusuf S., Reddy S., Ounpuu S., Et al., Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies, Circulation, 104, 23, pp. 2855-2864, (2001)
[3]
Lerner D.J., Kannel W.B., Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population, Am Heart J, 111, 2, pp. 383-390, (1986)
[4]
Gould K.L., Lipscomb K., Hamilton G.W., Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve, Am J Cardiol, 33, 1, pp. 87-94, (1974)
[5]
Tonino P.A.L., Fearon W.F., de Bruyne B., Et al., Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation, J Am Coll Cardiol, 55, 25, pp. 2816-2821, (2010)
[6]
Falk E., Shah P.K., Fuster V., Coronary plaque disruption, Circulation, 92, 3, pp. 657-671, (1995)
[7]
Berman D.S., Abidov A., Kang X., Et al., Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation, J Nucl Cardiol, 11, 4, pp. 414-423, (2004)
[8]
Hachamovitch R., Hayes S.W., Friedman J.D., Et al., Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography, Circulation, 107, 23, pp. 2900-2907, (2003)
[9]
Shaw L.J., Berman D.S., Maron D.J., Et al., Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy, Circulation, 117, 10, pp. 1283-1291, (2008)
[10]
Pijls N.H.J., Fearon W.F., Tonino P.A.L., Et al., Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study, J Am Coll Cardiol, 56, 3, pp. 177-184, (2010)